1 document found, page 1 of 1

Sort by Issue Date

Phase II study on paclitaxel in patients with recurrent, metastatic or locally ...

Witteveen, PO; van der Velden, J; Vergote, I; Guerra, C; Scarabeli, C; Demonty, G; Reed, N

BACKGROUND: No standard treatment options are available for patients with advanced, recurrent or metastatic vulvar carcinoma not amenable for locoregional treatment. PATIENTS AND METHODS: In this phase II study, patients with advanced vulvar cancer received paclitaxel (Taxol) every 3 weeks for up to 10 cycles. Primary objective was response rate. Secondary objectives were response duration and toxicity. Respons...


1 Results

Queried text

Refine Results

Author








Date


Document Type


Access rights


Resource


Subject